GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like AI Biotech, BioXcel Therapeutics, Files for $69M IPO February 12, 2018 5 Things Illumina's Management Wants You to Know February 1, 2017 Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017
Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback February 20, 2017
